Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-07-24 Sale |
2024-07-26 4:52 pm |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
7,772 | $18.06 | $140,360 | 107,571 (Direct) |
View |
2024-07-18 Sale |
2024-07-19 4:09 pm |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
12,625 | $18.2 | $229,804 | 57,772 (Direct) |
View |
2024-07-12 Sale |
2024-07-16 4:46 pm |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
9,189 | $18.02 | $165,578 | 146,695 (Direct) |
View |
2024-07-01 Sale |
2024-07-03 1:12 pm |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
912 | $18.01 | $16,428 | 159,209 (Direct) |
View |
2024-06-24 Sale |
2024-06-26 4:26 pm |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
9,260 | $18.19 | $168,427 | 80,498 (Direct) |
View |
2024-06-11 Sale |
2024-06-13 4:46 pm |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
1,586 | $18.06 | $28,637 | 180,602 (Direct) |
View |
2024-06-05 Sale |
2024-06-07 4:12 pm |
PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development |
8,656 | $18.08 | $156,460 | 184,099 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-07-24 Exercise |
2024-07-26 4:52 pm |
N/A N/A |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
7,772 | $10.21 | 107,571 (Direct) |
View |
2024-07-24 Exercise |
2024-07-26 4:52 pm |
N/A 2032-06-30 |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
7,772 | $0 | 107,571 (Direct) |
View |
2024-07-18 Exercise |
2024-07-19 4:09 pm |
N/A N/A |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
12,625 | $10.21 | 57,772 (Direct) |
View |
2024-07-18 Exercise |
2024-07-19 4:09 pm |
N/A 2032-06-30 |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
12,625 | $0 | 57,772 (Direct) |
View |
2024-07-12 Exercise |
2024-07-16 4:46 pm |
N/A N/A |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
9,189 | $10.21 | 146,695 (Direct) |
View |
2024-07-12 Exercise |
2024-07-16 4:46 pm |
N/A 2032-06-30 |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
9,189 | $0 | 146,695 (Direct) |
View |
2024-07-01 Exercise |
2024-07-03 1:12 pm |
N/A N/A |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
912 | $10.21 | 159,209 (Direct) |
View |
2024-07-01 Exercise |
2024-07-03 1:12 pm |
N/A 2032-06-30 |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
912 | $0 | 159,209 (Direct) |
View |
2024-06-24 Exercise |
2024-06-26 4:26 pm |
N/A N/A |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
9,260 | $10.21 | 80,498 (Direct) |
View |
2024-06-24 Exercise |
2024-06-26 4:26 pm |
N/A 2032-06-30 |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
9,260 | $0 | 80,498 (Direct) |
View |
2024-06-11 Exercise |
2024-06-13 4:46 pm |
N/A N/A |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
1,586 | $10.21 | 180,602 (Direct) |
View |
2024-06-11 Exercise |
2024-06-13 4:46 pm |
N/A 2032-06-30 |
PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer |
1,586 | $0 | 180,602 (Direct) |
View |
2024-06-05 Exercise |
2024-06-07 4:12 pm |
N/A N/A |
PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development |
8,656 | $10.21 | 184,099 (Direct) |
View |
2024-06-05 Exercise |
2024-06-07 4:12 pm |
N/A 2032-06-30 |
PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development |
8,656 | $0 | 184,099 (Direct) |
View |
2024-03-01 Option Award |
2024-03-01 5:29 pm |
2025-03-01 2034-02-28 |
PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development |
83,000 | $0 | 83,000 (Direct) |
View |
2023-03-01 Option Award |
2023-03-02 4:53 pm |
2024-03-01 2033-02-28 |
PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development |
95,000 | $0 | 170,000 (Direct) |
View |
2022-07-01 Option Award |
2022-08-31 4:15 pm |
N/A 2032-06-29 |
PepGen Inc. | PEPG | Mellion Michelle L See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |
2022-05-06 Option Award |
2022-05-10 6:53 pm |
N/A 2032-05-05 |
PepGen Inc. | PEPG | Mellion Michelle L See Remarks |
16,655 | $0 | 16,655 (Direct) |
View |